Latest Insider Transactions at Roivant Sciences Ltd. (ROIV)
This section provides a real-time view of insider transactions for Roivant Sciences Ltd. (ROIV). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Roivant Sciences Ltd. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Roivant Sciences Ltd.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 23
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,635
-1.11%
|
$6,540
$4.34 P/Share
|
|
May 20
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
12,127
-7.59%
|
$36,381
$3.7 P/Share
|
|
May 20
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
136,421
-10.75%
|
$409,263
$3.7 P/Share
|
|
May 20
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
139,791
-9.95%
|
$419,373
$3.7 P/Share
|
|
Apr 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
8,509
-0.6%
|
$25,527
$3.84 P/Share
|
|
Apr 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
5,107
-0.4%
|
$15,321
$3.84 P/Share
|
|
Apr 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
703
-0.44%
|
$2,109
$3.84 P/Share
|
|
Apr 25
2022
|
Dexcel Pharma Technologies Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
8,600
+0.01%
|
$25,800
$3.91 P/Share
|
|
Apr 22
2022
|
Dexcel Pharma Technologies Ltd. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
31,685
+0.03%
|
$95,055
$3.83 P/Share
|
|
Mar 30
2022
|
Matthew Gline CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
25,254
-1.76%
|
$101,016
$4.74 P/Share
|
|
Mar 30
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
33,686
-2.29%
|
$134,744
$4.84 P/Share
|
|
Mar 30
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,077
-1.28%
|
$8,308
$4.74 P/Share
|
|
Mar 30
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,486
-1.51%
|
$9,944
$4.84 P/Share
|
|
Mar 30
2022
|
Eric Venker President & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
15,092
-1.17%
|
$60,368
$4.74 P/Share
|
|
Mar 30
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
19,336
-1.48%
|
$77,344
$4.84 P/Share
|
|
Mar 25
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
7,281
-4.23%
|
$36,405
$5.06 P/Share
|
|
Mar 25
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
35,386
-2.35%
|
$176,930
$5.06 P/Share
|
|
Mar 25
2022
|
Eric Venker President & COO |
SELL
Open market or private sale
|
Direct |
80,045
-5.76%
|
$400,225
$5.06 P/Share
|
|
Mar 18
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
82,006
-5.16%
|
$410,030
$5.13 P/Share
|
|
Mar 18
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,153
-1.23%
|
$10,765
$5.13 P/Share
|
|
Mar 07
2022
|
Matthew Gline CEO |
SELL
Open market or private sale
|
Direct |
92,324
-5.49%
|
$461,620
$5.52 P/Share
|
|
Mar 07
2022
|
Rakhi Kumar Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
3,091
-1.74%
|
$15,455
$5.52 P/Share
|